These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5814355)

  • 1. [Function of glare protection--clinical effect of an ophthalmic solution urocanic acid, on protection from glare].
    Ichikawa H
    Ganka; 1969 Feb; 11(2):94-100. PubMed ID: 5814355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trial of improvement in dazzle resistance by the instillation of Correctol eyedrops].
    Chevaleraud JP; Sevel B; Andermann
    Bull Soc Ophtalmol Fr; 1981 Jan; 81(1):47-51. PubMed ID: 7011586
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protective effect of cis-urocanic acid eye-drops to the ocular inflammation induced by the ultra-violet radiation].
    Matsui M
    Nippon Ganka Gakkai Zasshi; 1970 Nov; 74(11):1489-93. PubMed ID: 5530174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protective effect of urocanic acid eye-drops to the ocular inflammation induced by the ultraviolet radiation].
    Matsui M; Tashiro T
    Nippon Ganka Gakkai Zasshi; 1967 Jun; 71(6):571-6. PubMed ID: 5624646
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dim the light! Glare problems in a world with ever increasing demands on visual acuity].
    Abrahamsson M; Thaung J; Sjöstrand J
    Lakartidningen; 1997 Oct; 94(41):3607-11. PubMed ID: 9411106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and toleration of oxymetazoline ophthalmic solution.
    Samson CR; Danzig MR; Sasovetz D; Thompson HS
    Pharmatherapeutica; 1980; 2(6):347-52. PubMed ID: 7433475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Vaccinium myrtillus anthocyanosides associated with betacarotenes on light sensitivity].
    Urso G
    Ann Ottalmol Clin Ocul; 1967 Sep; 93(9):930-8. PubMed ID: 5608903
    [No Abstract]   [Full Text] [Related]  

  • 8. Adaptation to glare.
    SIMONSON E
    Am J Ophthalmol; 1958 Sep; 46(3 Pt 1):353-5. PubMed ID: 13571343
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of prolonged treatment with anthocyanosides on light sensitivity].
    Zavarise G
    Ann Ottalmol Clin Ocul; 1968 Feb; 94(2):209-14. PubMed ID: 5745362
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug facilitated sexual assault using an over-the-counter ocular solution containing tetrahydrozoline (Visine).
    Spiller HA; Rogers J; Sawyer TS
    Leg Med (Tokyo); 2007 Jul; 9(4):192-5. PubMed ID: 17320456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Heusser et al: elevation of sympathetic activity by eprosartan in young male subjects.
    Rupp H
    Am J Hypertens; 2004 Mar; 17(3):281; author reply 281-3. PubMed ID: 15001205
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
    Pathak A; Hanon O; Negre-Pages L; Sevenier F;
    Fundam Clin Pharmacol; 2007 Apr; 21(2):199-205. PubMed ID: 17391293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thickness of the epidermis and concentration of urocanic acid on the posterolateral (more pigmented) and anteromedial (less pigmented) side of the arm].
    Král JA; Zenísek A; Strych A; Hais IM
    Cas Lek Cesk; 1968; 107(10):302-7. PubMed ID: 5664804
    [No Abstract]   [Full Text] [Related]  

  • 14. Macular pigment and visual performance under glare conditions.
    Stringham JM; Hammond BR
    Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.
    Chiba T; Kashiwagi K; Chiba N; Tsukahara S
    Br J Ophthalmol; 2006 Mar; 90(3):314-7. PubMed ID: 16488953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinastine ophthalmic solution (Elestat).
    Med Lett Drugs Ther; 2004 Apr; 46(1181):35-6. PubMed ID: 15114254
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.
    Edwards JD; Burka JM; Bower KS; Stutzman RD; Sediq DA; Rabin JC
    J Cataract Refract Surg; 2008 Sep; 34(9):1538-41. PubMed ID: 18721716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxymetazoline ophthalmic solution versus naphazoline solution in non-infectious conjunctivitis.
    Rybiczka R; Mauracher E
    Pharmatherapeutica; 1983; 3(6):376-81. PubMed ID: 6353428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast and glare sensitivity in diabetic patients with and without pan-retinal photocoagulation.
    Mackie SW; Walsh G
    Ophthalmic Physiol Opt; 1998 Mar; 18(2):173-81. PubMed ID: 9692039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrin-containing formulation.
    Gonzalez JR; Baiza-Duran L; Quintana-Hau J; Tornero-Montaño R; Castaneda-Hernandez G; Ortiz M; Alarcon-Oceguera F; Beltran-Loustaunau M; Cortez-Gastelum M; Garcidueñas-Mejia J; Gomez-Bastar P; Jimenez-Roman J; Korder-Ortega V; Paczka-Zapata J; Torres-Segura M; Velasco-Gallegos G
    J Clin Pharmacol; 2007 Jan; 47(1):121-6. PubMed ID: 17192510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.